Skip to main content

ADVERTISEMENT

Zachary Bessette

Managed Care Q&A
11/28/2018
Gary Goldstein, business manager of the Blood and Marrow Transplant Program at Stanford Health Care, discusses the changes needed for increased CAR-T administration in the outpatient setting as well as commercial and provider concerns about...
Gary Goldstein, business manager of the Blood and Marrow Transplant Program at Stanford Health Care, discusses the changes needed for increased CAR-T administration in the outpatient setting as well as commercial and provider concerns about...
Gary Goldstein, business manager...
11/28/2018
First Report Managed Care
Managed Care Q&A
02/28/2018
J Russell Hoverman, MD, PhD, the vice president of Quality Programs at Texas Oncology and the medical director of Managed Care for The US Oncology Network, discusses implementation of the Oncology Care Model in a pilot program.
J Russell Hoverman, MD, PhD, the vice president of Quality Programs at Texas Oncology and the medical director of Managed Care for The US Oncology Network, discusses implementation of the Oncology Care Model in a pilot program.
J Russell Hoverman, MD, PhD, the...
02/28/2018
First Report Managed Care
Managed Care Q&A
10/26/2017
Steve Miller, MD, MBA, chief medical officer of Express Scripts, discusses how payers are going to have to become innovative in order to pay the high prices associated with gene therapy.
Steve Miller, MD, MBA, chief medical officer of Express Scripts, discusses how payers are going to have to become innovative in order to pay the high prices associated with gene therapy.
Steve Miller, MD, MBA, chief...
10/26/2017
First Report Managed Care